Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
These signals affect insulin release, glucose metabolism, fat storage, and hunger signals
576.60 g/mol Purity 98% CAS No
Compared to insulins, GLP-1 RAs may also reduce the risk of specific obesity-associated cancers (OACs) [139]
Mechanism of Action (Based on Research) Preclinical studies suggest Semaglutide (GLP-1) may influence: Regulates appetite signals in the brain Slows gastric emptying, promoting satiety Supports blood glucose regulation Influences metabolic pathways Important: FDA-approved semaglutide (Wegovy) clinical trials showed participants lost an average of 12.4% of initial body weight over 68 weeks
US$ 21.99
US$ 28.66
US$ 28.92
US$ 24.75
US$ 26.50
